Electromedical Technologies, Inc. (EMED)
Electromedical Technologies, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Scottsdale, AZ, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $373,229. On trailing twelve-month figures it carries a trailing P/E of -0.22, a net margin of -6271.3%. Its beta of -7.68 implies it has historically moved less than the broad market.
Electromedical Technologies, Inc. operates within the U.S. market, specializing in the creation and distribution of bioelectronic medical devices specifically designed for pain management. The company's primary product is WellnessPro Plus, a prescription-based bioelectronic therapy tool utilized by both individual users and healthcare professionals to mitigate various forms of discomfort, including both persistent (chronic) and sudden (acute) pain. Established in 2002, the firm is headquartered in Scottsdale, Arizona.
Electromedical Technologies, Inc. is most often compared with the following Healthcare names: